Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.45 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3583014 | 1.00 | IDO1 (0.53) | IDO1TSHRBLMHTTALDH1A1 | |
| SCHEMBL59026 | 1.00 | IDO1 (0.53) | IDO1TSHRBLMHTTALDH1A1 | |
| SCHEMBL3596545 | 1.00 | IDO1 (0.53) | IDO1TSHRBLMHTTALDH1A1 | |
| Benzene SCHEMBL28873131 | 0.98 | IDO1 (0.52) | IDO1TSHRBLMHTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL22770167 | 0.98 | IDO1 (0.55) | IDO1TSHRBLMHTTALDH1A1 | |
| Bromide SCHEMBL9033434 | 0.98 | IDO1 (0.52) | IDO1TSHRBLMHTTALDH1A1 | |
| Water SCHEMBL28334394 | 0.98 | IDO1 (0.52) | IDO1TSHRBLMHTTALDH1A1 | |
| SCHEMBL29622997 | 0.94 | TSHR (0.48) | IDO1TSHRBLMHTTEPHX1 | |
| SCHEMBL29182252 | 0.94 | TSHR (0.48) | IDO1TSHRBLMHTTEPHX1 | |
| SCHEMBL2192515 | 0.94 | TSHR (0.48) | IDO1TSHRBLMHTTEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419305-B2 | Antimicrobial compositions | FIRMENICH SA (CH) | 2025-09-23 | — | — | US | claimed |
| US-20250136891-A1 | PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES | L'OREAL (FR) | 2025-05-01 | — | — | US | claimed |
| EP-4511463-A2 | PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES | L'OREAL (FR) | 2025-02-26 | — | — | EP | claimed |
| WO-2024250897-A1 | TETRAHYDRONAPHTHOL-PHOSPHINE PRE-TRANSITION METAL COMPLEX, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 中国石油化工股份有限公司 | 2024-12-12 | — | — | WO | claimed |
| WO-2024239969-A1 | 5,6,7,8-TETRAHYDRO-1-NAPHTHOL-PHOSPHINE POST-TRANSITION METAL COMPLEXES, PREPARATION METHOD THEREFOR, AND USE THEREOF | 中国石油化工股份有限公司 | 2024-11-28 | — | — | WO | claimed |
| US-20240000078-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2024-01-04 | — | — | US | claimed |
| WO-2023203098-A2 | PERFUME CONCRETE AND ABSOLUTE WHICH ARE OBTAINED BY ORGANIC (POLY)OL SOLVENT EXTRACTION FROM SOLID NATURAL SUBSTANCES | L'OREAL (FR) | 2023-10-26 | — | — | WO | claimed |
| US-11785945-B2 | Antimicrobial compositions | FIRMENICH SA (CH) | 2023-10-17 | — | — | US | claimed |
| CN-116670127-A | EGFR inhibitors and compositions and uses thereof | 贝达药业股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-116332722-A | Auxiliary agent for preparing cyclohexanol by cyclohexene hydration and application thereof | 沈阳化工研究院有限公司 | 2023-06-27 | — | — | CN | claimed |
| US-20220079151-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2022-03-17 | — | — | US | claimed |
| EP-4041727-B1 | ATF6 MODULATORS AND USES THEREOF | ALTOS LABS INC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12583836-B2 | Sulphonamide compounds | Anaxis Pharma Pty Ltd (AU) | 2026-03-24 | — | — | US | disclosed |
| EP-4707283-A1 | TETRAHYDRONAPHTHOL-PHOSPHINE PRE-TRANSITION METAL COMPLEX, AND PREPARATION METHOD THEREFOR AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2026-03-11 | — | — | EP | disclosed |
| US-12419305-B2 | Antimicrobial compositions | FIRMENICH SA (CH) | 2025-09-23 | — | — | US | disclosed |
| WO-2022074177-A1 | DYNAMIC KINETIC RESOLUTION OF ALCOHOLS BY ENANTIOSELECTIVE SILYLATION | Technische Universität Berlin (DE) | 2022-04-14 | — | — | WO | disclosed |
| CN-114260021-A | Nitrogen-doped carbon-supported iron-cobalt composite material and preparation method and application thereof | 中国科学院兰州化学物理研究所 | 2022-04-01 | — | — | CN | disclosed |
| US-20220096355-A1 | FRAGRANCE COMPOSITIONS | FIRMENICH SA (CH) | 2022-03-31 | — | — | US | disclosed |
| US-20220079151-A1 | ANTIMICROBIAL COMPOSITIONS | FIRMENICH SA (CH) | 2022-03-17 | — | — | US | disclosed |
| CN-111669971-B | Antimicrobial compositions | 弗门尼舍有限公司 | 2022-03-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000078-A1 | ANTIMICROBIAL COMPOSITIONS | MPO, GPX4, CUTA | IDO1 2302/4885TSHR 4716/4885BLM 1827/4885 |
| US-12583836-B2 | Sulphonamide compounds | MLKL, RIPK3, CASP1 | IDO1 687/4885TSHR 1614/4885BLM 4420/4885 |
| US-12419305-B2 | Antimicrobial compositions | MPO, GPX4, CUTA | IDO1 2302/4885TSHR 4716/4885BLM 1827/4885 |
| US-20220079151-A1 | ANTIMICROBIAL COMPOSITIONS | MPO, GPX4, CUTA | IDO1 2302/4885TSHR 4716/4885BLM 1827/4885 |
| US-11785945-B2 | Antimicrobial compositions | MPO, GPX4, CUTA | IDO1 2302/4885TSHR 4716/4885BLM 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.